Pasar al contenido principal

ESTRATEGIAS DE NUTRICION DE PRECISION PARA PACIENTES ONCOLOGICOS BASADAS EN SU CLASIFICACION INMUNOMETABOLICA.

PID2022-138295OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION IMDEA NUTRICIÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Silymarin-enriched extract from milk thistle activates thermogenesis in a preclinical model of high-fat-diet-induced obesity to relieve systemic meta-inflammation

  • Reguero, Marina
  • Reglero, Guillermo
  • Quintela, José Carlos
  • Ramos-Ruiz, Ricardo
  • Ramírez de Molina, Ana
  • Gómez de Cedrón, Marta
This article belongs to the Section Phytochemicals and Human Health., [Background]: Obesity and aging are associated with the progressive loss of brown adipose tissue (BAT), an increase in visceral white adipose tissue (vWAT), and a reduction in subcutaneous white adipose tissue (sWAT). The progressive expansion of visceral obesity promotes a low grade of systemic chronic inflammation (meta-inflammation), contributing to the onset of comorbidities such as type 2 diabetes mellitus (T2DM), metabolic syndrome, and even cancer. Thus, preserving the thermogenic activity of adipose tissue and improving the metabolic flexibility of sWAT could be an effective strategy to prevent the development of metabolic chronic diseases and promote healthy aging. Precision nutrition has emerged as a complementary approach to control the metabolic alterations associated with unhealthy obesity and aging. In a previous work, we described that a silymarin-enriched extract from milk thistle (Mthistle) increased markers of browning and thermogenesis in vitro in human differentiated adipocytes (SGBS)., [Objectives/methods]: Therefore, this study aims to evaluate the potential of Mthistle to activate thermogenesis in a preclinical model of high-fat diet (HFD)-induced obesity (DIO)., [Results]: Our results demonstrate that Mthistle increases systemic energy expenditure (EE), preserves body temperature after cold exposure, improves insulin resistance, and reduces inflammatory markers in WAT., [Conclusions]: Based on these results, silymarin-enriched extract from Mthistle may be proposed as a nutraceutical for the management of metabolic chronic diseases and/or accelerated aging., Funding was obtained by the Regional Government of Community of Madrid (NutriSION-CM Y2020/BIO-6350, P2018/BAA-4343-ALIBIRD2020-CM); Ministerio de Ciencia e Innovacion, Spain MCIN/AEI/10.13039/501100011033 (PID2019-110183RB-C21; PID2022-138295OB-I00); The European Regional Development Fund European Union “ERDF A way of making Europe”. Ramon Areces Foundation (CIVP19A5937); and the REACT EU Program FACINGLCOVID-CM (PD2022-004-REACT-EU) Marina Reguero obtained a predoctoral grant from the industrial predoctoral program of the Community of Madrid (IND2017/BIO-7826)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Randomized clinical trial in cancer patients shows immune metabolic effects exerted by formulated bioactive phenolic diterpenes with potential clinical benefits

  • Gómez de Cedrón, Marta
  • Moreno-Rubio, Juan
  • O Pascual, Victor de la
  • Alvarez, Beatriz
  • Villarino Sanz, Marta
  • Sereno, María
  • Gómez-Raposo, Cesar
  • Roa, Silvia
  • López Gómez, Miriam
  • Merino-Salvador, María
  • Jiménez-Gordo, Ana
  • Falagán Martínez, Sandra
  • Aguayo, Cristina
  • Zambrana, Francisco
  • Tabarés, Beatriz
  • Garrido-Rubiales, Beatriz
  • Cruz-Gil, Silvia
  • Fernández Díaz, Cristina M.
  • Fernández, Lara P.
  • Molina, Susana
  • Crespo, M. Carmen
  • Ouahid, Youness
  • Montoya, Juan Jose
  • Ramos-Ruiz, Ricardo
  • Reglero, Guillermo
  • Ramírez de Molina, Ana
  • Casado, Enrique
[Background]: Nutrients, including bioactive natural compounds, have been demonstrated to affect key metabolic processes implicated in tumor growth and progression, both in preclinical and clinical trials. Although the application of precision nutrition as a complementary approach to improve cancer treatments is still incipient in clinical practice, the development of powerful “omics” techniques has opened new possibilities for delivering nutritional advice to cancer patients. Precision nutrition may contribute to improving the plasticity and function of antitumor immune responses., [Objectives]: Herein, we present the results of a randomized, prospective, longitudinal, double-blind, and parallel clinical trial (NCT05080920) in cancer patients to explore the immune-metabolic effects of a bioactive formula based on diterpenic phenols from rosemary, formulated with bioactive alkylglycerols (Lipchronic© WO/2017/187000). The trial involved cancer patients, including those with lung cancer (LC), colorectal cancer (CRC), and breast cancer (BC), undergoing chemotherapy, targeted biological therapy, and/or immunotherapy. The main readouts of the study were the analysis of Lip on systemic inflammation, hemogram profile, anthropometry, lipid and glucose profiles, and tolerability. Additionally, a deep immune phenotyping of peripheral blood mononuclear cells (PBMCs) was performed to identify the functional effects of Lip on key mediators of the immune system., [Results]: Lip was well tolerated. The lung cancer subgroup of patients showed a reduction in biomarkers of systemic inflammation, including the neutrophil-to-lymphocyte ratio (NLR). Furthermore, modulation of key players in the immune system associated with the experimental treatment Lip compared to the control placebo (Pla) treatment was revealed, with particularities among the distinct subgroups of patients. Our results encourage further research to apply molecular nutrition-based strategies as a complementary tool in the clinical management of cancer patients, particularly in the current era of novel immunotherapies., [Clinical trial registration]: ClinicalTrials.gov, identifier NCT05080920, Funding was obtained by the Regional Government of Community of Madrid (P2018/BAA-4343-ALIBIRD2020-CM and NutriSION-CM Y2020/BIO-6350), Ministerio de Ciencia e Innovacion, Spain MCIN/AEI/10.13039/501100011033 (PID2019-110183RB-C21; PID2022-138295OB-I00), and by “ERDF A way of making Europe”, Ramon Areces Foundation (CIVP19A5937), and REACT EU Program FACINGLCOVID-CM (PD2022-004-REACT-EU) Comunidad de Madrid and The European Regional Development Fund (ERDF) European Union. Flow Cytometry was conducted by Flow Cytometry Unit, CNIC., being the Cytometer part of the Grant EQC2018-005009-P funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Excessive glycosylation drives thoracic aortic aneurysm formation through integrated stress response

  • Rochano-Ortiz, Antonio
  • Simó, Carolina
  • García-Cañas, Virginia
  • Gabandé-Rodríguez, Enrique
  • Mittelbrunn, María
  • Oller, Jorge
Rochano-Ortiz et al., [Background and aims]: Thoracic aortic aneurysms and dissections (TAADs) are depicted by aortic medial degeneration characterized by glycan-rich matrix accumulation. Marfan syndrome (MFS) is the most common inherited connective tissue disorder associated with TAAD. Although vascular smooth muscle cell metabolic dysfunction has emerged as a pathogenic driver of TAAD, surgical repair remains the mainstay of treatment. This study aimed to investigate the role of the hexosamine biosynthetic pathway (HBP) in sporadic and genetic TAAD pathophysiology., [Methods]: Hexosamine biosynthetic pathway activation was analysed in aortas from an MFS mouse model, a β-aminopropionitrile-induced non-genetic TAAD model, and patients with sporadic TAAD using transcriptomic and metabolomic approaches. Aortic dilatation was monitored by ultrasound imaging. Pharmacological inhibition of HBP and integrated stress response (ISR) was performed to assess their therapeutic potential., [Results]: Hexosamine biosynthetic pathway was up-regulated in both an MFS mouse model and β-aminopropionitrile-induced TAAD, as well as in aortic samples from MFS and sporadic TAAD patients. Enhanced HBP activity contributed to aortic dilatation and medial degeneration via vascular smooth muscle cell dysfunction and ISR activation. Inhibition of HBP or ISR reversed these effects in the MFS model., [Conclusions]: The HBP-ISR axis drives medial degeneration in TAAD. These findings identify HBP and ISR as a potential target in TAAD of both genetic and non-genetic origin., A.R.-O. is supported by the Conchita-Rábago Foundation 2024 grant. J.O. is supported by a Ramón y Cajal contract (RYC2021-033343-I) and grant from Spanish Ministerio de Ciencia e Innovación grant (PID2022-137730OA-I00) funded by MCIN/AEI/10.13039/501100011033/FEDER, EU; granted by Fundación MERCK-FEDER ‘Investigación clínica en enfermedades raras 2022’, Marfan Spanish Association (SIMA, www.Marfan.es) and by ‘V-Ayudas Muévete por los que no pueden 2021’. Research in M.M.’s lab was supported by European Research Council grant ERC-2021-CoG 101044248-LetTBe and the Y2020/BIO-6350 NutriSION-CM synergy grant from Comunidad de Madrid, Ministerio de Ciencia e Innovacion, Spain (grants PID2022-141169OB-I00 and PID2022-138295OB-I00). European Research Council. M.M.-L., G.A.-L., and G.A.-E. are funded by Instituto de Salud Carlos III through the projects PI20/01103, PI23/00100, and CP22/00100 (co-funded by European Regional Development Fund/European Social Fund ‘A way to make Europe’/‘Investing in your future’). J.L.M.-V. is supported by grant from Spanish Ministerio de Ciencia e Innovación (PID2022-136979OB-I00). L.M.B.-C. is supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCIII/FEDER PI22/00233). G.T.-T. and A.G. are supported by Spanish Society of Cardiology (SEC/FEC-INV-CLI 20/015). O.L. is supported by grant from Spanish Health Ministry or Spanish Ministerio de Sanidad (PI20/00923 Instituto Carlos III). J.F.N. is supported by grant from Spanish Health Ministry or Spanish Ministerio de Sanidad (PI21/00084 FIS) and a grant from Health Research Institute Valdecilla (INNVAL21/24). N.M-B. is supported by Spanish Health Ministry or Spanish Ministeiro de Sanidad (PI21/01126). M.J.F.-G. is supported by Spanish Health Ministry or Spanish Ministerio de Sanidad contract (FIS22/00140). J.M.R. has received funding from La Caixa Foundation (HR18-00068); Spanish Ministerio de Ciencia e Innovación grant PID2021-122388OB-100 funded by MCIN/AEI/10.13039/501100011033; and Instituto de Salud Carlos III (CIBER-CV CB16/11/00264); Fundació La Marató TV3 grant 202334-31, and Spanish Ministerio de Ciencia e Innovación contract FPI (BES-2016-077649) to M.J.R.-R. The CBMSO is supported by Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid. CBMSO is a Severo Ochoa Centers of Excellence (grant CEX2021-001154-S) funded by MICIN/AEI/10.13039/501100011033., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001154-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

KLRG1 identifies regulatory T cells with mitochondrial alterations that accumulate with aging

  • Soto-Heredero, Gonzalo
  • Gabandé-Rodríguez, Enrique
  • Carrasco, Elisa
  • Escrig-Larena, José Ignacio
  • Gómez de las Heras, Manuel M.
  • Delgado-Pulido, Sandra
  • Francos-Quijorna, Isaac
  • Blanco, Eva M.
  • Fernández-Almeida, Álvaro
  • Abia, David
  • Rodríguez, María Josefa
  • Fernández-Díaz, Cristina M.
  • Álvarez-Flores, María Beatriz
  • Ramírez de Molina, Ana
  • Jung, Sascha
  • del Sol, Antonio
  • Zorita, Virginia
  • Sánchez-Cabo, Fátima
  • Torroja, Carlos
  • Mittelbrunn, María
Recent studies using single-cell RNA sequencing technology have uncovered several subpopulations of CD4 T cells that accumulate with aging. These age-associated T cells are emerging as relevant players in the onset of inflammaging and tissue senescence. Here, based on information provided by single-cell RNA sequencing data, we present a flow cytometry panel that allows the identification of age-associated T cell subsets in systematic larger analysis in mice. We use this panel to evaluate at the single-cell level mitochondrial and senescence marks in the different age-associated CD4 T cell subpopulations. Our analysis identifies a subpopulation of regulatory T (T) cells that is characterized by the extracellular expression of the co-inhibitory molecule killer cell lectin-like receptor subfamily G member 1 (KLRG1) and accumulates with aging in humans and mice. KLRG1-expressing T cells display senescence features such as mitochondrial alterations, increased expression of cell-cycle regulators and genomic DNA damage. Functionally, KLRG1 T cells show a reduced suppressive activity in vivo accompanied by a pro-inflammatory phenotype., This study was supported by European Research Council grant ERC-2021-CoG 101044248-LetTBe, and the Y2020/BIO-6350 NutriSION-CM synergy grant from Comunidad de Madrid, Ministerio de Ciencia e Innovacion, Spain (grants PID2022-141169OB-I00 and PID2022-138295OB-I00). GENYAL Clinical Trials Platform of IMDEA Alimentación led by A. Ramírez de Molina and R. Ramos Ruiz conducted the volunteer recruitment and human clinical trial. Flow cytometry of human samples was conducted by Flow Cytometry Unit, CNIC, being the cytometer part of the grant EQC2018-005009-P funded by MCIN/AEI/10.13039/501100011033 and by ‘ERDF A way of making Europe’. G.S.-H. is supported by a FPI-UAM grant (Universidad Autónoma de Madrid). E.G.-R. was funded by a Juan de la Cierva grant (IJC2018-036850-I; Universidad Autónoma de Madrid). M.G. and J.I.E.-L. are supported by FPU grants (FPU19/02576 and FPU20/04066, respectively), both from Ministerio de Ciencia, Innovación y Universidades (Spain). E.C. is supported by SI4/PJI/2024-00166 from Comunidad de Madrid and UAM (Spain). S.D.-P. was funded by a PIPF grant (PIPF-2022/SAL-GL-25208), from Comunidad de Madrid (Spain). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evaluation of the ALIBIRD mHealth platform for care of patients with lung cancer: Prospective pilot study

  • Iniesta-Chamorro, Jose M.
  • Sereno, María
  • Garrido-Rubiales, Beatriz
  • Villarino Sanz, Marta
  • Espinosa-Salinas, Isabel
  • Falagán Martínez, Sandra
  • Rubio Romero, Gustavo
  • Moreno-Rubio, Juan
  • Tabarés, Beatriz
  • Martín, Yolanda
  • Hernández de Córdoba, Irene
  • Morales Parga, Maria
  • Molinero, Natalia
  • Moreno-Arribas, M. Victoria
  • Reglero, Guillermo
  • Ramírez de Molina, Ana
  • Gómez, Enrique J.
  • Casado, Enrique
Data Availability: The data supporting the findings of this study are not publicly available due to institutional and consortium restrictions on data sharing. The datasets include pseudonymized clinical and digital health information collected within the ALIBIRD research program. Access to deidentified data may be considered upon reasonable request to the corresponding author in compliance with applicable ethical approvals and data protection regulations., [Background]: Mobile health (mHealth) represents a promising instrument for optimizing symptom management and important lifestyle strategies that enhance self-care and the quality of health care for patients with cancer. The ALIBIRD mHealth platform is a digital health solution specifically designed for the telemonitoring of oncology patients, fostering patient empowerment and supporting clinical decision-making., [Objective]: The primary objective of this study was to evaluate the patient experience with the ALIBIRD platform. In addition, the study aimed to assess clinical outcomes, particularly in symptom management, nutritional status, and lifestyle, using patient-reported outcome measures (PROMs)., [Methods]: The evaluation was conducted over a 30-week period in patients with advanced lung cancer receiving active treatment. Outcome variables included usability, patient experience, symptom burden, lifestyle behaviors (diet, physical activity, and sleep), nutritional status, PROMs, and system-generated clinical alerts. Through the mobile app, patients reported symptoms and completed integrated REDCap (Research Electronic Data Capture) questionnaires assessing lifestyle behaviors and PROMs, while receiving personalized recommendations informed by nutrigenetic and gut microbiota assessments. Daily activity and sleep data were automatically captured using the Fitbit Inspire wearable. Clinicians remotely monitored patient data using a web-based dashboard and performed clinical actions when required, including phone calls, therapeutic adjustments, referrals, and appointment rescheduling. Statistical analysis included descriptive summaries and pre-post comparisons of clinical and patient-reported outcomes., [Results]: Out of 20 patients recruited for the study, 14 completed the intervention. The System Usability Scale yielded a score of 90, indicating high usability. Among the 14 completers, adherence to scheduled questionnaires ranged from 94% to 100% for several instruments, and wearable-based monitoring ranged from 66% to 96% across visits. Overall, the ALIBIRD platform collected and processed 3589 patient-reported outcomes related to physical activity, 3468 related to sleep, 679 on-demand symptom entries, and 1524 completed questionnaires. Clinically, 143 alerts were resolved within an average of 2.05 days, resulting in 2 referrals to emergency rooms and 2 early detections of disease progressions. Furthermore, more than 2100 personalized recommendations contributed to a 21% (3/14 patients) increase in adherence to the Mediterranean diet and a 14% (2/14 patients) increase in moderate physical activity., [Conclusions]: The evaluation of the ALIBIRD implementation yielded promising results in that it facilitated the adoption of healthier lifestyle habits while enhancing health self-management among oncology patients. The ALIBIRD mHealth platform emerges as an effective digital health tool that enables closer monitoring of patients and thereby more informed clinical decision-making., [Trial Registration]: ClinicalTrials.gov NCT05770869; https://clinicaltrials.gov/study/NCT05770869, This publication is funded by the Community of Madrid, TEC-2024/BIO-281 IALIBIRD-CM (ORDER 5696/2024, B.O.C.M. N°. 307, 12/26/2024). The underlying research was also supported by the ALIBIRD2020-CM program (S2018/BAA-4343): “Therapeutic precision nutrition formulations for cancer,” and by NutriSION-CM (Y2020/BIO-6350), funded by the Research and Innovation General Directorate of the Community of Madrid and cofinanced with European Union Structural Funds. Additional support was provided by grant PID2022-138295OB-I00 funded by MICIU/AEI/10.13039/501100011033 and by the European Union, the REACT-EU Program (FACINGLCOVID-CM project, Community of Madrid, and the European Regional Development Fund [ERDF]), and EU Structural Funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Neurochondrin drives colorectal cancer progression by modulating the PODXL-Ezrin axis and mitochondrial function

  • Garranzo-Asensio, María
  • Carral-Ibarra, Elisa
  • Montero-Calle, Ana
  • Gómez de Cedrón, Marta
  • Velázquez-Gutiérrez, Javier
  • Molina, Susana
  • Dziakova, Jana
  • Sanz-López, Rodrigo
  • Povès, Carmen
  • Ramírez de Molina, Ana
  • Martínez-Useros, Javier
  • Fernández-Aceñero, María Jesús
  • Bartolomé, Rubén A
  • Barderas, Rodrigo
Neurochondrin (NCDN) has been recently identified as overexpressed in liver metastatic colorectal cancer (CRC) cells compared to poorly metastatic isogenic counterparts. While its cellular function and role in cancer and CRC remain unknown, patient survival data indicate that elevated NCDN levels are associated with poor prognosis. After validating these observations in an independent patient cohort, we sought to investigate the role of NCDN in CRC progression using isogenic CRC cell models comprising poorly metastatic KM12C and liver-metastatic KM12SM cells, and poorly metastatic SW480 and lymph node-metastatic SW620 cells. Stable silencing of NCDN expression in these cell lines resulted in a significant reduction in their tumorigenic and metastatic properties in vitro. Furthermore, in vivo assays using nude mice and the KM12 cell model demonstrated that NCDN is essential for tumor initiation, growth, and liver metastasis of CRC cells. Proteomic profiling of NCDN-silenced cells uncovered a set of dysregulated proteins associated with cell adhesion, invasion, cell death, and differentiation, and mitochondrial dysfunction, emerging NCDN-PODXL-EZR axis as a critical mediator of CRC progression and involved in liver metastasis. Our findings position NCDN and their associated dysregulated proteins as drivers of CRC progression and promising targets for further investigation, This work was supported by the financial support from PI20CIII/00019 and PI23CIII/ 00027 grants from the AES-ISCIII program cofounded by FEDER funds to R.B. The financial support provided by the European Innovation Council (EIC) through the EIC Pathfinder Open 2023 project (Grant no. 101130574) to R.B., and the financial support of PID2022-138295OB-I00 funded by MICIU/AEI/10.13039/501100011033 to A.R.-M. is also acknowledged. M.G.-A. acknowledges the postdoctoral contract Margarita Salas for the requalification of the Spanish University System, Peer reviewed, Modelo experimental animal, Modelo experimental alternativo-NAM, Mamíferos - Roedores, in silico, in vitro - Tipos celulares - líneas inmortalizadas humanas, in vitro - Tipos celulares - líneas celulares primarias
Docta Complutense
Publicación Artículo científico (JournalArticle)

Sweet Taste Receptors’ Genetic Variability in Advanced Potential Targets of Obesity

  • Loria Kohen, Viviana Constanza
  • Wagner Reguero, Sonia
  • Fernández, Lara P.
  • Colmenarejo, Gonzalo
  • Cruz-Gil, Silvia
  • Espinosa, Isabel
  • Molina, Susana
  • Crespo, María Carmen
  • Aguilar-Aguilar, Elena
  • Marcos-Pasero, Helena
  • de la Iglesia, Rocío
  • Ramos Ruiz, Ricardo
  • Laparra-Llopis, Moisés
  • Ramírez de Molina, Ana
  • Gómez de Cedrón, Marta
Background: Obesity, mainly visceral obesity, causes a low-grade of chronic inflammation (meta-inflammation), associated with comorbidities such as type 2 diabetes, cardiovascular diseases, and certain cancers. Precision Nutrition aims to understand the bidirectional crosstalk between the genome and diet to improve human health. Additionally, by leveraging individual data, Precision Nutrition seeks to predict how people will respond to specific foods or dietary patterns, with the ultimate goal of providing personalized nutritional recommendations tailored to their unique needs and lifestyle factors, including poor dietary habits (e.g., high intake of sugar or saturated fatty acids, alcohol consumption, etc.) and sedentary habits, exacerbate obesity in genetically predisposed individuals. Genetic, metabolic, and environmental factors can play a crucial role during obesity. Objective: To investigate the effects of genetic variability in sweet taste receptors and their downstream signaling pathways in the gut–brain axis on anthropometry, biochemistry, and lifestyle variables. Methods: A sample of 676 volunteers (mean age of 42.22 ± 12 years, ranging from 18 to 73 years) from the database of the GENYAL platform for nutritional trials at the IMDEA Food Institute were included in this study. We present a first-in-class genetic chip, Glucosensing, designed to interrogate 25 single-nucleotide polymorphisms (SNPs) located in genes encoding sweet taste receptors and components of downstream signaling pathways. These include elements of the gut–brain axis and its associated metabolic networks, enabling a comprehensive analysis of individual variability in sweet taste perception and metabolic responses. Results: Several significant associations were found after correction for multiple comparisons, representing potential targets for personalized interventions.